Category: Biotechnology
Global Biotechnology
-
Biochips
... 12.8% over the analysis period 2024-2030. DNA Chip, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$14.7 Billion by the end of the analysis period. Growth ... Read More
-
Gas Chromatography Systems
... at a CAGR of 4.9% over the analysis period 2024-2030. Gas Chromatography Accessories & Consumables, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.8 Billion by ... Read More
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Forensic Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the ... Read More
-
Gel Documentation Systems
... at a CAGR of 4.1% over the analysis period 2024-2030. Gel Documentation Instruments, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$173.1 Million by the end ... Read More
-
Laboratory Informatics
... CAGR of 8.4% over the analysis period 2024-2030. Laboratory Information Management Systems (LIMS), one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$3.5 Billion by the end ... Read More
-
mRNA Platform
... CAGR of -2.7% over the analysis period 2024-2030. Covid-19 Vaccine Indication, one of the segments analyzed in the report, is expected to record a -6.3% CAGR and reach US$102.1 Billion by the end of the ... Read More
-
Drug Discovery Technologies
... at a CAGR of 8.7% over the analysis period 2024-2030. Small Molecule Drugs, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$92.7 Billion by the end ... Read More
-
Amino Acids
... CAGR of 6.0% over the analysis period 2024-2030. Glutamic Acid, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$13.6 Billion by the end of the analysis ... Read More
-
Animal Feed Additives
... at a CAGR of 5.4% over the analysis period 2024-2030. Amino Acids, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$20.7 Billion by the end of ... Read More
-
Microplate Systems
... CAGR of 4.6% over the analysis period 2024-2030. Microplate Readers, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$851.2 Million by the end of the analysis ... Read More
-
Biobanks
... 7.7% over the analysis period 2024-2030. Physical / Real Biobanks, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$108.4 Billion by the end of the analysis ... Read More
-
Biofuel Enzymes
... CAGR of 8.3% over the analysis period 2024-2030. Amylase, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$683.8 Million by the end of the analysis period. ... Read More
-
Antimicrobial Susceptibility Testing
... at a CAGR of 3.4% over the analysis period 2024-2030. Manual Products, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$1.5 Billion by the end of ... Read More
-
qPCR and dPCR Instrumentation
... 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. qPCR Instrumentation, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$11.3 Billion by the ... Read More
-
DNA Sequencing
... CAGR of 11.8% over the analysis period 2024-2030. DNA Sequencing Consumables, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$7.5 Billion by the end of the ... Read More
-
In Situ Hybridization (ISH)
... 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Fluorescence In Situ Hybridization (FISH), one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.1 ... Read More
-
RNA Analysis / Transcriptomics
... 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. RNA Analysis / Transcriptomics Reagents / Consumables, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and ... Read More
-
Proteomics
... 10.1% over the analysis period 2024-2030. Proteomics Reagents, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$49.2 Billion by the end of the analysis period. Growth ... Read More
-
Nanotechnology
... 11.3% over the analysis period 2024-2030. Nanocomposites, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$80.8 Billion by the end of the analysis period. Growth in ... Read More
-
Nanopatterning
... 17.7% over the analysis period 2024-2030. UV Nanoimprint Lithography Technology, one of the segments analyzed in the report, is expected to record a 17.0% CAGR and reach US$6.2 Billion by the end of the analysis ... Read More
-
Cancer Therapies
... CAGR of 10.4% over the analysis period 2024-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$112.8 Billion by the end of the analysis period. ... Read More
-
Marine Biotechnology
... CAGR of 8.4% over the analysis period 2024-2030. Biomaterials, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$6.5 Billion by the end of the analysis period. ... Read More
-
Cell Free Protein Expression
... 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Protein-Protein Interaction Application, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$193.3 Million by ... Read More
-
Coatings for Medical Devices
... 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Anti-Microbial Coatings, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$7.7 Billion by the ... Read More
-
Biosensors
... 7.2% over the analysis period 2024-2030. Non-wearable Biosensors, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.3 Billion by the end of the analysis period. Growth ... Read More